Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)

Date: 18.12.2019 · Reference: B9-0230/2019

Overall Result: 443 For
443 For
216 Against
33 Abstention
56 Did not vote
Filter by Country
← Go back